In September, 2016, multidisciplinary colleagues and I published and sold our second, in-depth and multidisciplinary analysis of the changes to and new directions in asbestos litigation.  The paper was anchored around law and science innovations, and implications for mass tort claiming. For that effort, I teamed with David Schwartz and other science people at Innovative

It appears Cardno ChemRisk may have been engaged to work for a talc defendant. Or maybe the company just sees a booming litigation topic ahead. Either way, pasted below is the link to and abstract for a new article by three of Cardno’s scientists, and a University of Michigan epidemiologist who is not David Garabrant.

The burgeoning roster of talc and ovarian cancer claims continues to grow. And now there are at least two uterine cancer claims. The underlying cases raise related insurance coverage issues. The coverage issues in turn raise questions about the science relevant to how injury is defined and how insurance triggers are defined.

There are both

A new ovarian cancer complaint cries out for genetic investigation. The facts suggesting that need are that the plaintiff developed ovarian cancer at age 45, and her mother died of ovarian cancer.  That type of history should raise a red flag for all involved lawyers – on either side – to investigate and think about

Add uterine cancer to the list of cancers now at issue in “personal use talc” litigation” that some also refer to as “cosmetic talc litigation.”  The allegations are in a new complaint filed in the Northern District of Illinois. The news arrives courtesy of HarrisMartin’s detailed coverage of the litigation.  The complaint is online.